Sensory neurons that respond to temperature, touch and pain have ways of adapting to repeated stimuli that can change how a ...
Journavx works by targeting a pain-signaling pathway involving sodium channels in the peripheral nervous system, which intercepts pain signals before they reach the brain. This approval marks the ...
Doctors at NexGenEsis Healthcare say they are revolutionizing pain relief with regenerative medicine
Dr. Abhishek Reddy and Dr. Joe Fuhrman stop by Houston Life to discuss their innovative approach to pain management.
The use of powerful synthetic opioids, such as sufentanil and remifentanil, during surgery is linked to a subsequent poor ...
The one-size-fits-all approach to pain management should be a thing of the past. But we’re still not there yet.
RBC Capital notes that the clinical review documents associated with Sector Perform-rated Vertex Pharmaceuticals (VRTX)’ recent approval of ...
A multistate pain management company made millions of dollars off unneeded injections into patients, turning them into 'human ...
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...
We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results